Bacopa monnieri for Health & Longevity - Quick Reference Sheet

Bacopa monnieri for Health & Longevity

Created on 09/06/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

A traditional Ayurvedic leaf extract taken daily for months. The most durable finding is a small gain in retaining newly learned material; several well-run trials found nothing. Evidence points to no benefit in established memory disease. Harms are mild and mostly digestive, easing when taken with a fatty meal. Most products tested did not contain what their labels claimed. (Full Review)

Protocol

Standard dose
300 mg daily
Leaf extract standardised to 50–55% bacosides; 600 mg ranked first for working memory.
Minimum duration
12 weeks
Twelve weeks before judging effect; shorter self-experiments cannot answer the question.
Best time of day
Morning with breakfast
Taken with fat. Evening dosing offers no known advantage.
Time to effect
Delayed verbal recall
6–12 weeks
Every memory finding required at least six weeks, with maximal effects at 12.
Speed of attention
12 weeks
Chronic dosing speeds performance on tasks that require sustained, timed responding.
Anxiety and stress reactivity
12 weeks
Lower anxiety and stress reactivity when dosing runs 12 weeks at 300 mg daily.

Benefits

Contraindications
  • Pregnancy and lactation
  • Uncontrolled hyperthyroidism (untreated Graves' disease, toxic nodular goitre)
  • Symptomatic bradycardia (resting heart rate under 50 bpm)
  • Second- or third-degree heart block
  • Muscarinic agonist use (cevimeline, pilocarpine)
  • Children and adolescents outside supervised trials
Key Interactions
  • Cholinesterase inhibitors (donepezil, rivastigmine)
  • Calcium channel blockers (amlodipine, diltiazem)
  • CYP3A4 and CYP2C19 substrates (statins, apixaban)
  • Warfarin and other CYP2C9 substrates
  • Thyroid hormone replacement (levothyroxine)
  • Over-the-counter antihistamines and sedating sleep aids (diphenhydramine)
  • Over-the-counter acid suppressants (omeprazole, esomeprazole)
  • Supplements with additive cholinergic effect (huperzine A, citicoline)
  • Sedative and calming supplements (ashwagandha, valerian, kava)
  • Cognitive training combined with Bacopa

Risk & Side Effects

  • High: Gastrointestinal upset
  • Medium: Slowed reaction time on speed-sensitive tasks; modest reduction in heart rate
  • Low: Cholinergic excess with muscarinic drugs; product that does not contain Bacopa
  • Speculative: Thyroid hormone elevation; effects on male fertility

Monitoring

Marker Target Why
Thyroid-stimulating hormone (TSH) 0.5–2.0 mIU/L Detects thyroid drift
Free thyroxine (free T4) 1.0–1.5 ng/dL Addresses the animal thyroxine signal
Alanine aminotransferase (ALT) Under 25 U/L men, 20 U/L women Screens for liver strain
Resting heart rate 50–70 bpm, or unchanged from baseline Catches cholinergic slowing
High-sensitivity C-reactive protein (hs-CRP) Under 1.0 mg/L Tracks the inflammatory axis
Delayed recall score on a validated memory test No established target; change from individual baseline Endpoint trials most consistently moved
International normalised ratio (INR) 2.0–3.0, per the anticoagulation indication Detects altered warfarin clearance

Cadence: Thyroid panel, liver enzymes, resting pulse and one memory test at baseline. Resting pulse weekly for the first month, then monthly. Thyroid panel and liver enzymes at 12 weeks, then every 6–12 months. Memory test at 12 weeks, then every 6 months, rotating versions. INR at 2 and 4 weeks after starting or stopping, for anticoagulated users only.

Qualitative Assessment

  • Ease of recalling material learned days earlier, rather than same-day recall
  • Subjective mental fatigue at the end of a demanding work block
  • Anxiety and stress reactivity in situations that reliably provoke them
  • Accuracy versus speed on habitual tasks, since the trade may shift toward accuracy
  • Dream vividness and sleep continuity, particularly if dosing has moved later in the day
  • Digestive comfort, stool frequency and reflux in the first four weeks